
ATOM Coalition
@atom_coalition
The Access to Oncology Medicines Coalition is a global initiative led by UICC that aims to increase access to #cancermedicines in LLMICs. #ATOMCoalition
ID: 1523931850275708928
https://www.uicc.org/who-we-work/networks/access-oncology-medicines-atom-coalition 10-05-2022 07:44:13
151 Tweet
416 Takipçi
83 Takip Edilen


We are excited to see our partner Bristol Myers Squibb launch their ASPIRE strategy, a 10-year commitment to improve access to life-saving treatments and #cancer medicines in low- and middle-income countries. 🌍💊

The UICC-led ATOM Coalition marks its second anniversary. 🌟 The Coalition has made significant strides in expanding access to essential cancer medicines in low- and lower middle-income countries (LLMICs). Read more➡️uicc.org/news/atom-coal…



The ATOM Coalition has signed a Memorandum of Understanding with the Ministry of Health, El Salvador, to improve access to essential cancer medicines. A major step towards implementing the country’s national cancer control plan! ➡️uicc.org/announcements/… Ministerio de Salud Union for International #CancerControl


At the #WhiteHouseAfricaCancerCareForum, Dr. Julie Gralow discussed several of ASCO’s global efforts in support of research, professional development, cancer care access & care delivery in Africa, which included establishing the Sub-Saharan Regional Council. #ASCOHealthEquity


The White House African Cancer Forum on July 15 focused on US efforts to build capacity in cancer control in Africa. UICC Board Member Miriam Mutebi highlighted national cancer programs and strategies reducing Africa's cancer burden. Missed it? Watch here. youtube.com/live/Wbn9_hjMo…

Over 80 UICC members and partners joined our Virtual Dialogue on ATOM Medicines Access Pathways, in collaboration with IDA Foundation. It addressed global medicine accessibility, regulatory pathways and ATOM-secured medicines. Watch the sessions: uicc.org/events/virtual…




🌟 Exciting News! 🌟 📣MPP, ATOM Coalition, IDA Foundation, and The Max Foundation announce U.S. FDA approval for Hetero's generic #nilotinib for chronic myeloid #leukaemia (#CML). 🎉This milestone enhances access to #cancer treatment options in low- and middle-income



The FDA approval of Hetero's generic #nilotinib is a key step in improving access to #cancer treatments in LMICs. It highlights the Union for International #CancerControl-led ATOM Coalition's success in leveraging partnerships to save lives. @MPP IDA Foundation The Max Foundation

Access to medicines for #NCDs, including #cancer, is a challenge—but progress is within reach. Join the Union for International #CancerControl-led ATOM Coalition on 23 Jan at 14:00 CET to explore 5 key strategies for improving access. NCD Alliance Université de Genève bit.ly/4hIXeL1



A new The Lancet Oncology commentary highlights how the Union for International #CancerControl-led ATOM Coalition is breaking barriers to cancer treatment in low- and middle-income countries—through licensing, donations, and stronger supply chains. bit.ly/41jg70k

Yesterday, partners gathered at the Union for International #CancerControl offices in Geneva for the annual ATOM Coalition meeting, marking the Coalition’s third anniversary. Held during #WHA78, the event was a moment to reflect on progress and look ahead in expanding access to essential #cancermedicines.


We’re proud to see ATOM Coalition partner MedicinesPatentPool spotlighted on World Intellectual Property Organization (WIPO)’s #MissionImagination podcast! 🔗 Watch the episode and find out more about how we’re partnering to address barriers to medicines access for all: uicc.org/atom/atom-coal…

📘 ATOM Coalition has released its first Health Financing Case Studies on Georgia, Kenya, the Philippines & Zambia — offering insights to improve access to cancer care & essential medicines: uicc.org/news-and-updat…
